Bluechiip Limited

ASX:BCT ISIN:AU000000BCT7

Bluechiip Ltd ASX BCTBluechiip Ltd (ASX:BCT) understands that every sample - stem cells, blood, eggs, sperm and other biospecimens - is critical, so our objective is to manage each one with optimal quality in the most efficient way. Bluechiip's advanced management solution is the only one that provides sample temperature with ID in cryogenic environments to. Most importantly, this delivers confidence in every sample.

Bluechiip's unique patented technology is a MEMS-based wireless tracking solution that contains no electronics. It represents a generational change from current tracking methods such as labels (hand-written and pre-printed), barcodes (linear and 2D), and Radio Frequency Identification. Bluechiip tags are either embedded or manufactured into storage products such as vials or bags. Each product can be easily identified, and critical information such as sample temperature, is detected by readers and stored in the Bluechiip software. In addition to functioning in extreme temperatures, the Bluechiip(R) Advanced Sample management solution can survive autoclaving, gamma irradiation sterilization, humidification, centrifuging, cryogenic storage and frosting.

Bluechiip's technology has applications in healthcare, including in cryogenic storage facilities (biobanks and biorepositories), pathology, clinical trials and forensics. Other key markets include cold-chain logistics/supply chain, security/defence, industrial/manufacturing and aerospace/aviation.

Bluechiip: Delivering confidence in every sample.

 

 
    
            

View in Other Languages

News

Bluechiip Limited (ASX:BCT) Open Briefing

🕔10/28/2022 12:01:27 PM 702

In this OpenBriefing Bluechiip Limited (ASX:BCT) (FRA:1BL) Managing Director Andrew McLellan Discusses Growing customer base, repeat orders, pipeline growth and FujiFilm Irvine Scientific Progress.

Read Full Article

Bluechiip Limited (ASX:BCT) Quarterly Activities Report

🕔10/28/2022 11:39:22 AM 790

Bluechiip Limited (ASX:BCT) (FRA:1BL), a leader in the development of advanced sample management solutions for harsh environments, is pleased to release the company's Appendix 4C - Quarterly Cashflow report and update for the quarter ended 30 September 2022.

Read Full Article

Bluechiip Limited (ASX:BCT) FY22 Annual Report

🕔8/26/2022 9:47:37 AM 2111

Bluechiip Limited (ASX:BCT) (FRA:1BL) understands that every biological sample - stem cells, blood, eggs, sperm and other biospecimens - is critical, so our objective is to manage each one with optimal quality in the most efficient way.

Read Full Article

Bluechiip Limited (ASX:BCT) Open Briefing

🕔7/28/2022 10:45:11 AM 1221

Open Briefing interview with Bluechiip Limited (ASX:BCT) MD Andrew McLellan.

Read Full Article

Bluechiip Limited (ASX:BCT) Quarterly Activities Report

🕔7/28/2022 10:41:31 AM 920

Bluechiip Limited (ASX:BCT) (FRA:1BL), a leader in the development of advanced sample management solutions for harsh environments, is pleased to release the company's Appendix 4C - Quarterly Cashflow report and update for the quarter ended 30 June 2022.

Read Full Article

Bluechiip Limited (ASX:BCT) Open Briefing

🕔4/28/2022 3:03:18 PM 1115

Open Briefing interview with Bluechiip Limited (ASX:BCT) (FRA:1BL) MD Andrew McLellan. In this Open Briefing Andrew discusses sales growth accelerating and expected to continue, following the launch of Bluechiip's own product range in November 2021.

Read Full Article

Bluechiip Limited (ASX:BCT) Quarterly Activities Report

🕔4/28/2022 2:58:43 PM 864

Bluechiip Limited (ASX:BCT) (FRA:1BL), a leader in the development of advanced sample management solutions for harsh environments, is pleased to release the Group's Appendix 4C - Quarterly Cashflow report and update for the quarter ended 31 March 2022.

Read Full Article

Bluechiip Limited (ASX:BCT) Open Briefing Interview with MD Andrew McLellan

🕔1/27/2022 9:54:20 AM 2220

In this Open Briefing(R), Bluechiip Limited (ASX:BCT) (FRA:1BL) MD Andrew McLellan discusses cash receipts from initial orders and deliveries of own product range, expectation for increasing revenues based on existing orders and growing enquiry pipeline, new patent award and developer kit sales and OEM negotiations.

Read Full Article

Bluechiip Limited (ASX:BCT) Quarterly Activities Report

🕔1/27/2022 9:49:25 AM 1790

Bluechiip Limited (ASX:BCT) (FRA:1BL), a leader in the development of advanced sample management solutions for harsh environments, is pleased to release its Appendix 4C - Quarterly Cashflow report and update for the quarter ended 31 December 2021.

Read Full Article

Bluechiip Limited (ASX:BCT) Secures FDA Registration and CE IVD Certification

🕔11/30/2021 10:05:01 AM 3171

Bluechiip Limited (ASX:BCT) (FRA:1BL), a leader in the development of advanced sample management solutions for harsh environments, today announced the recent registration of Bluechiip's own branded cryovials with the United States.

Read Full Article
###

73,592 COMPANY PROFILE VIEWS

  • This Page Viewed: (Last 7 Days: 217) (Last 30 Days: 1101) (Since Published: 55291) 

Company Data

    Headquarters
  • 1 Dalmore Drive
    Caribbean Business Park
    Scoresby VIC 3179 AUSTRALIA
  • Telephone
  • +61-3-9763-9763 
  • Fax
  • +61-3-9763-9764 
  • Principal Sector
  • Infrastructure & Technology 
  • Principal Industry
  • Healthcare 
  • Homepage
  • www.bluechiip.com

Company Reports